[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: Patients with covid-19 who use curcumin in addition to first-line drugs during treatment. Intervention group receive two capsules of CURCUDEN\u00ae every 12 hours in addition to the main treatment based on national guidelines for the treatment of hospitalized patients with COVID-19. Curcuden 35 is a drug used by Alborz Nanomed tech Company.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group: Patients with covid-19 who use placebo in addition to first-line drugs during treatment. Control group receive two capsules of placebo every 12 hours in addition to the main treatment based on national guidelines for the treatment of hospitalized patients with COVID-19.", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}]

[{"arm_notes": "", "treatment_id": 362, "treatment_name": "Curcumin", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]